Are the gene-patent storm clouds dissipating? A global snapshot

Nature Biotechnology

Volumn 33, Issue 4, 2015, Pages 347-352

  Liddicoat, Johnathon ^a   Whitton, Tess ^a   Nicol, Dianne ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOINFORMATICS; DIAGNOSTIC TEST; DRUG METABOLISM; GENE SEQUENCE; GENETIC SCREENING; HUMAN; HUMAN GENOME; LICENSING; PATENT; PRIORITY JOURNAL; CYTOGENETICS; GENETICS; INTERNATIONAL COOPERATION; LEGISLATION AND JURISPRUDENCE; UNITED STATES;

CYTOGENETICS; GENETIC TESTING; GENETICS; INTERNATIONALITY; PATENTS AS TOPIC; UNITED STATES;

EID: 84926665166     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.3182     Document Type: Article

References (48)

1. Cho, M.K. et al. J. Mol. Diagn. 5, 3-8 (2003).
2. Carbone, J. et al. Nat. Biotechnol. 28, 784-791 (2010).
3. Cook-Deegan, R., Chandrasekharan, S. & Angrist, M. Nature 458, 405-406 (2009).
4. US Secretary's Advisory Committee on Genetics, Health and Society. Gene patents and licensing practices and their impact on patient access to genetic tests (SACGHS, Bethesda, Maryland) http://oba.od.nih.gov/SACGHS/sacghs- documents.html#GHSDOC-011 (2010).
5. Hawkins, N. Genet. Med. 13, 320-324 (2011).
6. Caulfield, T. et al. Nat. Biotechnol. 24, 1091-1094 (2006).
7. Gaisser, S. et al. Nature 458, 407-408 (2009).
8. N icol, D. Community Genet. 8, 228-234 (2005).
9. N icol, D. & Liddicoat, J. Aust. Health Rev. 37, 281-285 (2013).
10. Jensen, K. & Murray, F. Science 310, 239-240 (2005).
11. S chauinger, S. The human gene patent report http://hgpr. org/finalHGPR.pdf (2012).
12. Holman, C.M. 80 UMKC L. Rev. 563 (2012). http:// dx.doi.org/10.2139/ssrn.2001574
13. Holman, C.M. Nat. Biotechnol. 30, 1054-1058 (2012).
14. Pressman, L. Life Sciences Law & Industry Report 6, 329 (2012).
15. Rosenfeld, J.A. & Mason, C.E. Genome Med. 5, 27 (2013).
16. Van Zimmerman, E. et al. in Breast Cancer Gene Research and Medical Practices (eds. Gibbon, S. et al.) (2014).
17. Association for Molecular Pathology v. Myriad Genetics, Inc. 133 S Ct 3027 (2013).
18. Gold, E.R. & Cook-Deegan, R. Sci. Transl. Med. 5, 192ed9 (2013).
19. N oonan, K.E. Game over for Myriad-update. Patent Docs http://www.patentdocs.org/2015/02/game-overfor- myriad-update.html (16 February 2015).
20. McKernan, K.J. et al. Nat. Biotechnol. 31, 884-887 (2013).
21. Graff, G.D. et al. Nat. Biotechnol. 31, 404-410 (2013).
22. Mayo Collaborative Services v. Prometheus Laboratories Inc. 132 S Ct 1289 (2012).
23. Alice Corporation Pty Ltd v. CLS Bank International 134 S Ct 1537 (2014).
24. Haanes, E.J. & Cànaves, J.M. Nat. Biotechnol. 30, 758-760 (2012).
25. D'Arcy v. Myriad Genetics Inc. [2014] FCFCA 115.
26. Matthijs, G. et al. Nat. Biotechnol. 31, 704-710 (2013).
27. Jefferson, O.A. et al. Nat. Biotechnol. 31, 1086-1093 (2013).
28. Hopkins, M.M. et al. Nat. Biotechnol. 25, 185-187 (2007).
29. Kers, J.G. et al. Eur. J. Hum. Genet. 22, 1155-1159 (2014).
30. Huys, I. et al. Nat. Rev. Genet. 13, 441-448 (2012).
31. Huys, I. et al. Nat. Biotechnol. 27, 903-909 (2009).
32. http://omim.org/entry/164400.
33. http://www.omim.org/entry/183086.
34. http://www.epo.org/searching/essentials/patentfamilies/ definitions.html.
35. Moore, K.A. Berkley Tech. L.J. 20, 1521-1526 (2005).
36. Lemley, M.A. & Shapiro, C. J. Econ. Perspect. 19, 75-98 (2005).
37. Cook-Deegan, R. et al. Genet. Med. 12, S15-S38 (2010).
38. Instrumentation Laboratory. Instrumentation Laboratory wins patent infringement and unfair competition trial against Diagnostica Stago relating to reagents for hemostasis diagnostics (4 May, 2009).
39. E uropean Techno-Economic Policy Support. The role of patents in the development and clinical use of genetic tests. https://www.sussex.ac.uk/webteam/gateway/file. php?name=sc30-wp3.pdf&site=25 (2008).
40. E valuation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Genet. Med. 13, 67-76 (2011).
41. Kujovich, J.L. Genet. Med. 13, 1-16 (2011).
42. http://stats.oecd.org/index.aspx?DataSetCode=HEALTH-STAT
43. E uropean Union Committee of Experts on Rare Diseases. 2012 report on the state of the art of rare disease activities in Europe. (EUCERD) http://ec.europa.eu/health/rare-diseases/publications/ index-en.htm#anchor1-more (2012).
44. World Intellectual Property Organization. 2013 World intellectual property indicators. http://www. wipo.int/edocs/pubdocs/en/intproperty/941/wipo- pub-941-2013.pdf (2013).
45. Baldwin, A.L. & Cook-Deegan, R. Genome Med. 5, 8 (2013).
46. N icol, D. & Liddicoat, J. J. Law. Inform. Sci. 22, 32-54 (2012).
47. S herkow, J.S. & Scott, C. Nat. Biotechnol. 32, 620- 620 (2014).
48. Conley, J.M. & Cook-Deegan, R. N.C.J.L. Tech. 15, 597-637 (2014).